"10.1371_journal.pone.0131456","plos one","2015-07-06T00:00:00Z","Alexander Boes; Holger Spiegel; Nadja Voepel; Gueven Edgue; Veronique Beiss; Stephanie Kapelski; Rolf Fendel; Matthias Scheuermayer; Gabriele Pradel; Judith M Bolscher; Marije C Behet; Koen J Dechering; Cornelus C Hermsen; Robert W Sauerwein; Stefan Schillberg; Andreas Reimann; Rainer Fischer","Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Aachen, Germany; RWTH Aachen University, Institute of Molecular Biotechnology, Aachen, Germany; Zentrum für Infektionsforschung, Wuerzburg, Germany; TropIQ Health Sciences, Nijmegen, The Netherlands; Radboud university medical center, Nijmegen, The Netherlands","Conceived and designed the experiments: AB HS KJD RFe GP. Performed the experiments: AB GE HS JMB NV MS SK VB CCH MCB. Analyzed the data: AB HS RFe SK MS JMB CCH MCB KJD RWS. Contributed reagents/materials/analysis tools: RFi AR SS GP KJD RWS. Wrote the paper: AB HS SK RFi GP AR SS RWS.","JMB, KJD and RWS are employees of TropIQ Health Sciences B.V. KJD and RWS hold stock in TropIQ Health Sciences B.V. AB, HS, GE, VB, AR, and RFi are inventors of a patent application, title: Multi-component-multi-stage malaria vaccine, application Number: 140011550.2–1412. MCB, NV, SK, RFe, MS, GP, CCH and SS declare no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2015","07","Alexander Boes","AB",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
